SenesTech, Inc.SNESEarnings & Financial Report
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
Revenue
$625.0K
Gross Profit
$409.0K
Operating Profit
$-1.6M
Net Profit
$-1.6M
Gross Margin
65.4%
Operating Margin
-258.2%
Net Margin
-258.6%
YoY Growth
36.2%
EPS
$-0.87
Financial Flow
SenesTech, Inc. Q2 2025 Financial Summary
SenesTech, Inc. reported revenue of $625.0K (up 36.2% YoY) for Q2 2025, with a net profit of $-1.6M (down 2.0% YoY) (-258.6% margin). Cost of goods sold was $216.0K, operating expenses totaled $2.0M.
Key Financial Metrics
| Total Revenue | $625.0K |
|---|---|
| Net Profit | $-1.6M |
| Gross Margin | 65.4% |
| Operating Margin | -258.2% |
| Report Period | Q2 2025 |
SenesTech, Inc. Annual Revenue by Year
SenesTech, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.2M).
| Year | Annual Revenue |
|---|---|
| 2025 | $2.2M |
| 2024 | $1.9M |
| 2023 | $1.2M |
| 2022 | $1.0M |
SenesTech, Inc. Quarterly Revenue & Net Profit History
SenesTech, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $421.0K | -16.0% | $-1.8M | -428.5% |
| Q3 2025 | $690.0K | +43.2% | $-1.3M | -188.1% |
| Q2 2025 | $625.0K | +36.2% | $-1.6M | -258.6% |
| Q1 2025 | $485.0K | +16.9% | $-1.7M | -343.3% |
| Q4 2024 | $501.0K | +69.8% | $-1.3M | -250.5% |
| Q3 2024 | $482.0K | +33.9% | $-1.5M | -313.9% |
| Q2 2024 | $459.0K | +50.5% | $-1.6M | -345.1% |
| Q1 2024 | $415.0K | +78.1% | $-1.8M | -441.4% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $415000 | $459000 | $482000 | $501000 | $485000 | $625000 | $690000 | $421000 |
| YoY Growth | 78.1% | 50.5% | 33.9% | 69.8% | 16.9% | 36.2% | 43.2% | -16.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $5.5M | $4.0M | $4.4M | $3.3M | $3.6M | $10.4M | $14.6M | $12.8M |
| Liabilities | $862000 | $923000 | $798000 | $767000 | $734000 | $3.4M | $3.3M | $3.3M |
| Equity | $4.6M | $3.1M | $3.7M | $2.5M | $2.9M | $7.0M | $11.3M | $9.6M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-1.8M | $-1.6M | $-1.4M | $-1.2M | $-1.6M | $-1.1M | $-1.4M | $-1.7M |